Parainfluenza Virus 3, Human
"Parainfluenza Virus 3, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.
Descriptor ID |
D010224
|
MeSH Number(s) |
B04.820.455.600.650.700.735
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Parainfluenza Virus 3, Human".
Below are MeSH descriptors whose meaning is more specific than "Parainfluenza Virus 3, Human".
This graph shows the total number of publications written about "Parainfluenza Virus 3, Human" by people in this website by year, and whether "Parainfluenza Virus 3, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parainfluenza Virus 3, Human" by people in Profiles.
-
Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies. Nat Microbiol. 2024 Aug; 9(8):2128-2143.
-
Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity. J Immunol. 2024 May 01; 212(9):1450-1456.
-
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. J Virol. 2019 02 15; 93(4).
-
Characterizing the Cellular Immune Response to Parainfluenza Virus 3. J Infect Dis. 2017 07 15; 216(2):153-161.
-
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes. Cytotherapy. 2016 12; 18(12):1515-1524.
-
Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol. 2006 Feb; 80(4):1629-36.
-
A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med. 2000 Jan; 6(1):35-40.
-
Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine. 1998 Aug-Sep; 16(14-15):1423-32.
-
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994 Apr; 32(1):13-36.
-
Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis. 1993 Sep; 12(9):699-701.